Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 4, 2004

View Archived Issues

Targeting macrophage NF-kappaB activity may improve arthritis in vivo

Risedronate found effective in osteoporotic women treated with gastric acid inhibitors

Lipid profile changes found with exemestane in breast cancer patients

Novel 5-HT6 receptor ligands designed by GSK scientists

Two series of MCH receptor antagonists developed at Neurocrine

Millennium presents new ALK5 inhibitors and their potential applications

Ono researchers develop novel chemokine CCR5 antagonists

New ZAP70 and Syk kinase inhibitors claimed by NeoGenesis

New beta-secretase inhibitors under evaluation at GSK

KuDOS and Maybridge collaborate to develop new PARP inhibitors

NeuroSearch scientists prepare and test new KCNQ channel modulators

Serotonin receptor agonists for treatment of ocular hypertension and glaucoma

Development of novel topoisomerase inhibitors for solid tumor therapy

Angelini to launch prulifloxacin in Italy

Pyrazine nucleosides target hepatitis C virus polymerase

Fast track status for doripenem for nosocomial pneumonia

Promising antifungal compound effective in vitro and in vivo

Kahalalide F enters phase II trials for severe psoriasis

Novel low molecular weight anti-HIV agents by Merck & Co.

Start-up of Merck Pharma GmbH

Nuvelo to gain worldwide rights to alfimeprase

Approvable letter for Nascobal Nasal Spray

Pivotal study compares Numax to Synagis for RSV

Maxim to close Ceplene treatment protocol and withdraw NDA

Axcan launches URSO Forte

Reata Discovery licenses novel anticancer compounds

MD-1100 enters phase I study for IBS

Treatment phase begins in pivotal TRIUMPH study of eculizumab for PNH

Sosei launches U.S. company targeting CNS disorders

Sucampo and Takeda enter collaboration and license agreement for lubiprostone

Antiinflammatory mechanism of ajulemic acid examined in vitro

Everolimus improves methotrexate efficacy in RA

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan. 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for January 13, 2025
Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal
BioWorld
The J.P. Morgan (JPM) Healthcare Conference in San Francisco kicked off with a resounding bang as Johnson & Johnson (J&J) disclosed plans to acquire...
Proteomics study explores how protein changes influence disease
BioWorld Science
Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to...
Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance
BioWorld
Sana Biotechnology Inc. CEO Steve Harr said “cool and transformative science” led to his firm’s latest strides in type 1 diabetes, and the “very generalizable...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.